Financhill
Sell
46

MRNA Quote, Financials, Valuation and Earnings

Last price:
$49.69
Seasonality move :
34.09%
Day range:
$45.66 - $47.68
52-week range:
$22.28 - $55.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
9.32x
P/B ratio:
1.95x
Volume:
13.1M
Avg. volume:
13.6M
1-year change:
30.35%
Market cap:
$18.2B
Revenue:
$1.9B
EPS (TTM):
-$7.26

Earnings Data

Next earnings date for MRNA
Apr 30
2026
Most recent earnings per share
-$2.11
Beat by $0.54
(Feb 13/2026)
Consensus Estimate
-$2.64
(Feb 13/2026)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MRNA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
04/30/2026 Q1 $241M -- -- -$2.10 --
02/13/2026 Q4 $623.9M $678M -$2.11 -$2.64 $0.54
11/06/2025 Q3 $869.9M $1B -$0.51 -$2.16 $1.65
08/01/2025 Q2 $112.6M $142M -$2.13 -$3.00 $0.87
05/01/2025 Q1 $115.3M $108M -$2.52 -$3.11 $0.59
02/14/2025 Q4 $941.1M $966M -$2.91 -$2.73 -$0.18
11/07/2024 Q3 $1.2B $1.9B $0.03 -$1.94 $1.97
08/01/2024 Q2 $134.9M $241M -$3.33 -$3.36 $0.03
05/02/2024 Q1 $125.3M $167M -$3.08 -$3.55 $0.48
02/22/2024 Q4 $2.5B $2.8B $0.55 -$0.99 $1.54
11/02/2023 Q3 -- $1.8B -$9.53 -- --
06/30/2023 Q2 -- $344M -$3.62 -- --
03/31/2023 Q1 -- $1.9B $0.20 -- --
12/31/2022 Q4 -- $5B $3.62 -- --
09/30/2022 Q3 -- $3.3B $2.53 -- --
06/30/2022 Q2 -- $4.7B $5.24 -- --
03/31/2022 Q1 -- $6.1B $8.58 -- --
12/31/2021 Q4 -- $7.1B $11.29 -- --
09/30/2021 Q3 -- $5B $7.68 -- --
06/30/2021 Q2 -- $4.4B $6.45 -- --
03/31/2021 Q1 -- $1.9B $2.84 -- --
12/31/2020 Q4 -- $570.7M -$0.69 -- --
09/30/2020 Q3 -- $157.9M -$0.59 -- --
06/30/2020 Q2 -- $66.4M -$0.31 -- --
03/31/2020 Q1 -- $8.4M -$0.35 -- --
12/31/2019 Q4 -- $14.1M -$0.37 -- --
09/30/2019 Q3 -- $17M -$0.37 -- --
06/30/2019 Q2 -- $13.1M -$0.41 -- --
03/31/2019 Q1 -- $16M -$0.40 -- --
12/31/2018 Q4 -- $35.4M -$0.44 -- --
09/30/2018 Q3 -- $41.8M -$0.26 -- --
06/30/2018 Q2 -- $28.9M -$0.28 -- --
03/31/2018 Q1 -- $29M -$0.23 -- --
12/31/2017 Q4 -- $91.9M -$0.12 -- --
09/30/2017 Q3 -- $42.5M -$0.21 -- --

Moderna, Inc. Earnings Questions

  • How Much did Moderna, Inc. Generate in Revenue Last Quarter?

    Moderna, Inc. reported $678M worth of top line sales in its most recent quarter.

  • Did Moderna, Inc. Beat Earnings Last Quarter?

    Moderna, Inc. announced earnings per share of -$2.11 which represents a beat of analyst forecast a -$2.64 per share.

  • Is Moderna, Inc. Profitable?

    Moderna, Inc. reported $226M that represents $0.58 per share over the last quarter.

  • What is the Analyst Consensus for Moderna, Inc. EPS Next Year?

    Moderna, Inc.'s earnings are forecast to decrease from -$7.25 per share to -$7.91 per share next year representing a decrease of -7.82%.

  • When is Moderna, Inc.'s Earnings Date?

    Moderna, Inc.'s next earnings date is April 30, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
44
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
73
HYMC alert for Feb 19

Hycroft Mining Holding Corp. [HYMC] is up 3.81% over the past day.

Buy
57
GLBE alert for Feb 19

Global-e Online Ltd. [GLBE] is up 4.19% over the past day.

Sell
37
ACLS alert for Feb 19

Axcelis Technologies, Inc. [ACLS] is down 1.71% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock